EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Current Features

Advertisement

Current features

The Silent Document Revolution Unblocking Clinical Trials

For all the innovation reshaping clinical research, one part of the process has remained stubbornly analog: the documents. Protocols, Statistical Analysis Plans (SAP...
Continue Reading →
Current features

Beyond the IDMC: The Value of Safety Review Committees

Continuous monitoring of safety and efficacy data in clinical trials is a fundamental component of modern clinical research. Because monitoring is complex and involv...
Continue Reading →
Current features

Patient-Derived Tumour Organoids for Precision Screening: Operationalising GxPLevel Quality for Translational Reliability

There is a persistent gap between preclinical promise and clinical reality in oncology drug development. Two-dimensional cell culture systems derived from animal mod...
Continue Reading →
Current features

Optimising Clinical Trials for the Era of Self-Injectable Combination Products

Self-administered injectable drug–device combination (DDC) products are entering a phase of accelerated therapeutic innovation. Demographic change, chronic disease t...
Continue Reading →
Current features

Next-Generation Risk-Based Monitoring: The Role of AI in Clinical Trial Oversight

Clinical trial monitoring has traditionally relied on routine on site visits and exhaustive source data verification (SDV) to ensure patients’ safety and data integr...
Continue Reading →
Current features

From Start-up to Sustainability: The New Reality of Research Site Operations

From Episodic Challenges to Structural Conditions in Clinical Research Clinical research sites remain indispensable as the operational backbone of the clinical trial...
Continue Reading →
Catalyst: 12th January 2026
Quotient

Company Profiles